Results
Akums Q4 FY26 PAT Rises 8% YoY to ₹81 Crore
Akums Drugs held a conference call to discuss Q4 and FY26 results, reporting a 9.7% YoY revenue growth to ₹1,158 crore and a 61.6% YoY EBITDA jump to ₹152 crore.
Management provided a strategic update
